Taisho licenses Moberg’s MOB-015 in Japan

4 October 2019 - Deborah Wilkes

Premium

Taisho Pharmaceutical has signed an exclusive Japanese licensing agreement for MOB-015, Moberg Pharma's novel topical terbinafine formulation for treating nail fungus.

Click tags below for more information on topics:

Taisho Moberg

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: